Business Context and Reporting Period
Company: Biorestorative Therapies, Inc.
Filing Type: Form 8-K (Current Report)
Date: May 29, 2014
Context: The filing discloses presentation materials intended for use at the Marcum Microcap Conference on May 29, 2014, and for future investor communications. The materials are furnished under Regulation FD and are not deemed "filed" for liability purposes under Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence and availability of presentation materials (Exhibit 99.1) rather than to report financial results.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is procedural, announcing the release of summary presentation materials to the public.
Guidance, Outlook, and Risks
- Management Commentary: Management intends to use the presentation materials to discuss the Company's business with investors, lenders, and other stakeholders.
- Outlook: The materials speak as of May 29, 2014. The Company explicitly disclaims any obligation to update the materials or reflect events occurring after this date.
- Risks/Contingencies: The filing notes that the information is summary in nature and should be considered in the context of other SEC filings and public announcements.
Investor Verification Checklist
- Verify the content of the "Presentation Materials" (Exhibit 99.1) referenced in this filing, as the 8-K itself contains no financial data.
- Confirm the availability of the presentation materials on the Company's Investor Relations website (www.biorestorative.com), where they are posted for 90 days.
- Review other recent SEC filings (e.g., 10-K, 10-Q) for actual financial performance metrics, as this 8-K does not contain them.